Sudden Cardiac Arrest After Blood Return in High-Risk Dialysis Patients

Primary Mechanisms of Cardiac Arrest

Intradialytic hypotension, defined as systolic BP drop ≥20 mmHg or MAP drop ≥10 mmHg, occurs in approximately 25% of all hemodialysis sessions and directly predisposes to coronary and cerebral ischemic events through hypoperfusion, according to the American Journal of Kidney Diseases 1.
The blood return phase represents a critical period when rapid volume shifts can precipitate acute hypotension in patients with impaired cardiovascular reserve, as noted by the American Journal of Kidney Diseases 1.

Ventricular fibrillation/ventricular tachycardia accounts for 62% of cardiac arrests during hemodialysis, with a rate of 7 events per 100,000 dialysis sessions, as reported by Praxis Medical Insights 2.
Dynamic electrolyte fluctuations create a dysrhythmogenic state that persists for 4-5 hours after dialysis, particularly in patients with underlying structural cardiac abnormalities, according to Praxis Medical Insights 2, 3.

Left ventricular hypertrophy, present in almost 80% of dialysis patients, serves as a substrate for both systolic and diastolic dysfunction and further impairs diastolic filling when combined with hemodynamic stress, as noted by Praxis Medical Insights 2, 4.
Heart failure is present in approximately 31% of patients at dialysis initiation, with cardiovascular disease accounting for at least 40% of deaths in end-stage renal failure patients, according to Praxis Medical Insights 4.

Hyperkalemia is the primary cause of life-threatening cardiac dysrhythmias in patients with chronic renal failure, with cardiovascular causes accounting for at least 40% of deaths and 20% being sudden cardiac death, as reported by Praxis Medical Insights 2.
Maintaining serum potassium within 3.5-4.5 mmol/L shows the lowest risk of ventricular fibrillation, cardiac arrest, or death, according to Praxis Medical Insights 2.

Peripheral vascular disease indicates widespread atherosclerosis and is associated with defective reactivity of both resistance and capacitance vessels during hemodialysis sessions, as noted by the American Journal of Kidney Diseases 1.
Beta-blockers, commonly used in dialysis patients with prior CABG and hypertension, may be removed during dialysis, leading to rebound tachycardia and increased myocardial oxygen demand after the procedure, according to Praxis Medical Insights 2.

The most common error is failing to recognize that diabetic CKD patients with cardiovascular disease, left ventricular dysfunction, age ≥65 years, and history of CABG represent the highest-risk subgroup for sudden cardiac death during dialysis, as noted by the American Journal of Kidney Diseases and Praxis Medical Insights 1, 2.
Electrolyte monitoring must extend 4-5 hours post-dialysis, as the dysrhythmogenic state persists well beyond the dialysis session itself, according to Praxis Medical Insights 2, 3.